Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Starpharma Holdings Ltd (SPHRY)

Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,963
  • Shares Outstanding, K 41,204
  • Annual Sales, $ 2,830 K
  • Annual Income, $ -10,530 K
  • 60-Month Beta 1.09
  • Price/Sales 9.61
  • Price/Cash Flow N/A
  • Price/Book 1.10
Trade SPHRY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 10/05/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6301 unch
on 06/21/24
0.8356 -24.59%
on 05/30/24
-0.1799 (-22.21%)
since 05/20/24
3-Month
0.6301 unch
on 06/21/24
0.9419 -33.10%
on 04/22/24
-0.2199 (-25.87%)
since 03/21/24
52-Week
0.6301 unch
on 06/21/24
2.8105 -77.58%
on 07/24/23
-1.8649 (-74.75%)
since 06/21/23

Most Recent Stories

More News
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

CLXPF : 3.0200 (-1.31%)
BABYF : 0.1480 (-1.33%)
SHIEF : 0.0220 (+22.22%)
INNPF : 0.1995 (-3.67%)
LEXX : 2.73 (-1.80%)
DFFN : 6.60 (+11.68%)
FTRPF : 5.7460 (-2.32%)
INM : 0.2508 (-5.54%)
ARHH : 7.6500 (-4.38%)
VNRX : 0.6105 (+0.91%)
AVCRF : 0.1280 (-1.54%)
SPHRY : 0.6301 (-4.59%)
Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

SPHRY : 0.6301 (-4.59%)
SPL.AX : 0.092 (-3.16%)
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

VNRX : 0.6105 (+0.91%)
LEXX : 2.73 (-1.80%)
DFFN : 6.60 (+11.68%)
INM : 0.2508 (-5.54%)
CLXPF : 3.0200 (-1.31%)
BABYF : 0.1480 (-1.33%)
SHIEF : 0.0220 (+22.22%)
INNPF : 0.1995 (-3.67%)
FTRPF : 5.7460 (-2.32%)
ARHH : 7.6500 (-4.38%)
AVCRF : 0.1280 (-1.54%)
SPHRY : 0.6301 (-4.59%)
Starpharma to Webcast Live at Life Sciences Investor Forum September 17th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 49.1350 (+0.48%)
SPHRY : 0.6301 (-4.59%)
ASX : 11.27 (-1.31%)
Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has completed additional antiviral testing for SPL7013 against SARS‑CoV-2 in studies conducted in the laboratory of internationally recognised virology...

SPL.AX : 0.092 (-3.16%)
SPHRY : 0.6301 (-4.59%)
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 49.1350 (+0.48%)
SPHRY : 0.6301 (-4.59%)
SPL.AX : 0.092 (-3.16%)
VNRX : 0.6105 (+0.91%)
KMPH : 5.81 (-0.34%)
ARHH : 7.6500 (-4.38%)
IOM.VN : 5.400 (-7.69%)
LIFE : 1.9000 (+2.70%)
SWKH : 16.60 (-2.30%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 2.73 (-0.36%)
XPHYF : 0.2836 (-31.13%)
Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced progress with development, regulatory and manufacturing activities associated with a nasal spray for protection against COVID-19 based on the company’s...

SPL.AX : 0.092 (-3.16%)
SPHRY : 0.6301 (-4.59%)

Business Summary

Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually...

See More

Key Turning Points

3rd Resistance Point 0.6301
2nd Resistance Point 0.6301
1st Resistance Point 0.6301
Last Price 0.6301
1st Support Level 0.6301
2nd Support Level 0.6301
3rd Support Level 0.6301

See More

52-Week High 2.8105
Fibonacci 61.8% 1.9776
Fibonacci 50% 1.7203
Fibonacci 38.2% 1.4630
Last Price 0.6301
52-Week Low 0.6301

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar